Free Trial

Ultralife (ULBI) Stock Forecast & Price Target

+0.16 (+1.36%)
(As of 07/23/2024 ET)

Ultralife - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 1 Wall Street analysts who have issued ratings for Ultralife in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for ULBI.

Consensus Price Target

17.25% Upside
High Forecast$14.00
Average Forecast$14.00
Low Forecast$14.00

According to the 1 analysts' twelve-month price targets for Ultralife, the average price target is $14.00. The highest price target for ULBI is $14.00, while the lowest price target for ULBI is $14.00. The average price target represents a forecasted upside of 17.25% from the current price of $11.94.

TypeCurrent Forecast
7/24/23 to 7/23/24
1 Month Ago
6/24/23 to 6/23/24
3 Months Ago
4/25/23 to 4/24/24
1 Year Ago
7/24/22 to 7/24/23
Consensus Rating
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$14.00$13.00$13.00N/A
Forecasted Upside17.25% Upside34.99% Upside34.99% UpsideN/A
Get Ultralife Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter.

ULBI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ULBI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ultralife Stock vs. The Competition

TypeUltralifeComputer and Technology CompaniesS&P 500
Consensus Rating Score
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside17.85% Upside577.35% Upside9.52% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2 of 5 stars
 Boost TargetBuy ➝ Buy$13.00 ➝ $14.00+35.53%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:14 PM ET.

ULBI Forecast - Frequently Asked Questions

What is Ultralife's forecast for 2024?

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Ultralife is $14.00, with a high forecast of $14.00 and a low forecast of $14.00.

Should I buy or sell Ultralife stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ultralife in the last twelve months. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ULBI shares.

Does Ultralife's stock price have much upside?

According to analysts, Ultralife's stock has a predicted upside of 35.53% based on their 12-month stock forecasts.

What analysts cover Ultralife?

Ultralife has been rated by research analysts at Benchmark in the past 90 days.

Do Wall Street analysts like Ultralife more than its competitors?

Analysts like Ultralife more than other "computer and technology" companies. The consensus rating for Ultralife is Buy while the average consensus rating for "computer and technology" companies is Moderate Buy. Learn more on how ULBI compares to other companies.

This page (NASDAQ:ULBI) was last updated on 7/23/2024 by Staff

From Our Partners